Two of China’s major CROs were named to Deloitte Technology Fast 500 Asia Pacific list, an award that recognizes the fastest growing technology companies in the Asia Pacific region. It was WuXi PharmaTech’s (NYSE: WX) sixth appearance on the list, a remarkable achievement given that the company was formed in December 2000. For Sundia MediTech, an even younger company, it was the second year in a row to be included in Fast 500.

Two of China’s major CROs were named to Deloitte Technology Fast 500 Asia Pacific list, an award that recognizes the fastest growing technology companies in the Asia Pacific region. It was WuXi PharmaTech’s (NYSE: WX) sixth appearance on the list, a remarkable achievement given that the company was formed in December 2000. For Sundia MediTech, an even younger company, it was the second year in a row to be included in Fast 500.

“We are pleased and honored to receive this award again,” said Dr. Ge Li, Chairman and Chief Executive Officer of WuXi PharmaTech. “It speaks to the soundness of our long-term business model and the effort, talent, and customer focus of our scientists. At WuXi PharmaTech, we continue to expand our pharmaceutical R&D service capabilities and capacity to best serve our customers and to sustain long-term revenue growth.”

“It is a great honor for Sundia to be recognized by such a respected institution in such an important program for the second consecutive year,” said Dr. Xiaochuan Wang, Chairman and CEO of Sundia. “This award reflects our sustained growth over the past several years especially in the global financial and economical turmoil.”

Deloitte Technology has been assembling the Fast 500 Asia Pacific list for the past eight years. Companies are drawn from countries across the Asia Pacific region including Australia, China/Hong Kong, India, Japan and others.